Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.

Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S.

J Pain. 2008 Jun;9(6):506-21. doi: 10.1016/j.jpain.2007.12.010. Epub 2008 Apr 10.

2.

Low-dose vaporized cannabis significantly improves neuropathic pain.

Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H.

J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.009. Epub 2012 Dec 11.

3.

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.

Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH.

Neuropsychopharmacology. 2009 Feb;34(3):672-80. doi: 10.1038/npp.2008.120. Epub 2008 Aug 6.

4.

Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.

Wallace MS, Marcotte TD, Umlauf A, Gouaux B, Atkinson JH.

J Pain. 2015 Jul;16(7):616-27. doi: 10.1016/j.jpain.2015.03.008. Epub 2015 Apr 3.

5.

An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.

Wilsey B, Marcotte TD, Deutsch R, Zhao H, Prasad H, Phan A.

J Pain. 2016 Sep;17(9):982-1000. doi: 10.1016/j.jpain.2016.05.010. Epub 2016 Jun 7.

PMID:
27286745
6.

Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.

Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I.

Anesthesiology. 2007 Nov;107(5):785-96.

PMID:
18073554
7.

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.

Ware MA, Wang T, Shapiro S, Robinson A, Ducruet T, Huynh T, Gamsa A, Bennett GJ, Collet JP.

CMAJ. 2010 Oct 5;182(14):E694-701. doi: 10.1503/cmaj.091414. Epub 2010 Aug 30.

8.

Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.

Hunault CC, Böcker KB, Stellato RK, Kenemans JL, de Vries I, Meulenbelt J.

Psychopharmacology (Berl). 2014 Dec;231(24):4723-33. doi: 10.1007/s00213-014-3630-2. Epub 2014 May 31.

PMID:
24879495
9.

Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H.

Psychopharmacology (Berl). 2002 Jun;161(4):331-9. Epub 2002 Apr 19.

PMID:
12073159
10.

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis.

Rog DJ, Nurmikko TJ, Friede T, Young CA.

Neurology. 2005 Sep 27;65(6):812-9.

PMID:
16186518
11.

Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.

Kraft B, Frickey NA, Kaufmann RM, Reif M, Frey R, Gustorff B, Kress HG.

Anesthesiology. 2008 Jul;109(1):101-10. doi: 10.1097/ALN.0b013e31817881e1.

PMID:
18580179
12.

The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study.

Gormsen L, Finnerup NB, Almqvist PM, Jensen TS.

Anesth Analg. 2009 Apr;108(4):1311-9. doi: 10.1213/ane.0b013e318198317b.

PMID:
19299805
13.

Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.

Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA.

J Spinal Cord Med. 2002 Summer;25(2):100-5.

PMID:
12137213
14.

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.

Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U.

JAMA. 2003 Oct 1;290(13):1757-62.

PMID:
14519710
15.

Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.

Deshpande A, Mailis-Gagnon A, Zoheiry N, Lakha SF.

Can Fam Physician. 2015 Aug;61(8):e372-81. Review.

16.

Venlafaxine for neuropathic pain in adults.

Gallagher HC, Gallagher RM, Butler M, Buggy DJ, Henman MC.

Cochrane Database Syst Rev. 2015 Aug 23;(8):CD011091. doi: 10.1002/14651858.CD011091.pub2. Review.

PMID:
26298465
17.

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):142-50. doi: 10.1016/j.drugalcdep.2010.12.010. Epub 2011 Feb 18.

19.

The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.

Eisenberg E, Ogintz M, Almog S.

J Pain Palliat Care Pharmacother. 2014 Sep;28(3):216-25. doi: 10.3109/15360288.2014.941130. Epub 2014 Aug 13.

PMID:
25118789
20.

A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.

Lynch ME, Cesar-Rittenberg P, Hohmann AG.

J Pain Symptom Manage. 2014 Jan;47(1):166-73. doi: 10.1016/j.jpainsymman.2013.02.018. Epub 2013 Jun 4.

PMID:
23742737

Supplemental Content

Support Center